PDGFR & cKIT Gene Mutation Analysis (GIST) – Dubai, UAE

Executive Summary & Core Metrics

This targeted genetic analysis detects actionable mutations in the PDGFRA (exons 12, 14, 18) and KIT (exons 9, 11, 13, 17) genes from tumor tissue, providing critical guidance for imatinib therapy in Gastrointestinal Stromal Tumors. The test is performed using gold-standard Sanger sequencing with 99.9 percent per-base accuracy.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Processing.
Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval coordinated directly with the treating hospital or clinic.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The PDGFR and cKIT gene mutation analysis is a precision molecular assay that identifies specific genetic alterations driving GIST pathogenesis. Detection of a mutation in either gene confirms eligibility for targeted tyrosine kinase inhibitor therapy, directly influencing progression-free survival. Absence of these mutations (wild-type GIST) necessitates broader molecular profiling to identify alternative therapeutic pathways. This analysis is essential before initiating systemic therapy and is performed exclusively on archival tumor tissue specimens or fresh biopsy material.

Feature	Our Test (Sanger Sequencing)	NGS Panel Alternative
Methodology	Gold-standard Sanger Sequencing	Next-Generation Sequencing
Precision	99.9% per-base accuracy	High, but may miss low-level mosaicism
Turnaround Time	7–8 business days	10–21 days
Cost in UAE	2,000 AED	2,500–3,500 AED

Physician Insight & Safety Protocols

“This targeted mutation analysis is pivotal for personalized GIST management; a positive result correlates with imatinib sensitivity, but clinical context and multidisciplinary review remain essential for therapeutic decisions. Secure tissue retrieval and chain-of-custody documentation ensure diagnostic integrity throughout the pre-analytical phase.” — Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011.

Advisory Notice

Do not discontinue prescribed medication without consulting your physician. Genetic findings must be interpreted by an oncologist or clinical geneticist in the context of full histopathological correlation and imaging data.

Exclusion Criteria & Red Flags

Exclusion Criteria

This test is not suitable for individuals under 18 years without specialist pediatric oncology consultation. A valid physician prescription is mandatory for all non-surgical cases.
Not indicated for routine pre-surgery clearance, pregnancy evaluation, or travel clearance.

Emergency Red Flags

If you experience severe abdominal pain, hematemesis, melena, or symptoms of bowel obstruction, visit an emergency department immediately do not wait for genetic test results.

Patient FAQ & Clinical Guidance

1. What is the clinical purpose of PDGFR and cKIT mutation testing for GIST?

Detecting a PDGFRA or KIT mutation confirms eligibility for targeted TKI therapy, directly influencing progression-free survival. Positive mutations predict response to imatinib, while a lack of mutation (wild-type) indicates alternative treatments or further molecular profiling. This analysis is crucial before initiating systemic therapy.

2. How is the sample collected and what preparation steps are needed?

A tumor tissue specimen is required either as a formalin-fixed paraffin-embedded block or fresh biopsy slides. Our logistics team coordinates directly with your hospital or clinic for Secure Medical Courier Solid Tissue Specimen Retrieval. A physician prescription is mandatory no fasting or medication discontinuation is needed. This test is not performed for surgery or pregnancy clearance.

3. Is the PDGFR and cKIT test covered by UAE insurance and how can I verify coverage?

Most UAE insurers cover this genetic test when prescribed by an oncologist. Direct billing confirmation is available via WhatsApp. Send your insurance card copy and request to +971 54 548 8731 for instant eligibility check. Our team processes approvals within 2 hours, ensuring a cashless experience.

UAE Regulatory & Data Privacy Adherence

This medical service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All testing is performed under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) quality management, ensuring international diagnostic standards. DHA and MOHAP standard nomenclature is applied throughout.

Clinical & Logistical Metadata

Test Name	PDGFR & cKIT Gene Mutation Analysis (GIST)
Price (AED)	2,000.00 AED
Turnaround Time	7–8 Business Days
Sample Type / Matrix	Archival Tissue Specimen (FFPE Block or Biopsy Slides) – Secure Medical Courier Solid Tissue Specimen Retrieval coordinated with the treating hospital or clinic.
Methodology Used	Sanger Sequencing
ICD-10-CM Code	C49.A
LOINC Code	92856-4
DHA Facility License & Laboratory Address Invariants	DHA Facility License Number: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| Corporate Lab: DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians